Онкопедиатрия. 2015; 2: 409-413
Использование пресепсина (sCD14-ST) в качестве маркера сепсиса при критических состояниях
https://doi.org/10.15690/onco.v2.i4.1468Аннотация
В статье изложен клинический случай примитивной нейроэктодермальной опухоли левой височной кости у 8-летнего ребенка. Представлены данные лабораторных исследований и интенсивной терапии.
Список литературы
1. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: re sults of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010; 36:222–31.
2. Rangel-Frausto MS, Pittet D, Costigan M. et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273(2):117–23.
3. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003.
4. Hunziker S, Hugle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B, Dick W, Eriksson U, Trampuz A. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 2010, 92:138–148.
5. Christ-Crain M, Müller B. Procalcitonin in bacterial infections — hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–60.
6. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764– 769.
7. Головня ЕГ, Сотников АВ, Байкова ВН, Салтанов АИ. Возможности использования нового биомаркера сепсиса — пресепсина. Вестник интенсивной терапии. 2015;2:23–28.
8. Yoshihiko Nakamura, Hiroyasu Ishikura, Takeshi Nishida, Yasumasa Kawano, Rie Yuge, Reiko Ichiki, Akira Murai. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiology. 2014;14:88.
9. Демидова В.С., Ушакова Т.А., Звягин А.А., Бобровников А.Э., Медова О.В., Коряков И.А., Баранова А.А., Самадурова Л.Л., Кучейник А.Ш. Пресепсин — от науки к практике: клиническая значимость маркеров сепсиса при инфекционных осложнениях у хирургических больных и пациентов с ожоговой травмой (ФГБУ «Институт хирургии им. А.В. Вишневского», Москва). Тезисы XIX Всероссийской научно-практической конференции «Консолидация науки и практики в лабораторной медицине», Москва, МВЦ «Крокус Экспо», 25–27 марта 2014.
10. Козлова Е.М., Шунькина Г.Л., Чумак Н.М, Запевалова Т.А. Уровень пресепсина крови у новорожденных детей (ГБУЗ НО «Детская городская клиническая больница № 1», Нижний Новгород). Тезисы XIX Всероссийской научно-практической конференции «Консолидация науки и практики в лабораторной медицине», Москва, МВЦ «Крокус Экспо», 25–27 марта 2014.
11. Makarova P., Galstyan G, Krechetova A, Gemdjian.E, Garandja T, Tichomirov D, Parovichnikova E. Usefulness of presepsin (PSP) for assessment of sepsis in leukopeniс patients (pts). National Scientific Center for Hematology. Moscow, Russia, 18 сентября 2014.
Oncopediatrics. 2015; 2: 409-413
Use of Presepsin (Scd14-St) Аs A Marker оf Sepsis in Critical Conditions
https://doi.org/10.15690/onco.v2.i4.1468Abstract
In current article we described a case report of primitive neuroectodermal tumor of left temporal bone in a child of 8 years. Laboratory and intensive care data is presented below.
References
1. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: re sults of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010; 36:222–31.
2. Rangel-Frausto MS, Pittet D, Costigan M. et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273(2):117–23.
3. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003.
4. Hunziker S, Hugle T, Schuchardt K, Groeschl I, Schuetz P, Mueller B, Dick W, Eriksson U, Trampuz A. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am 2010, 92:138–148.
5. Christ-Crain M, Müller B. Procalcitonin in bacterial infections — hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–60.
6. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17:764– 769.
7. Golovnya EG, Sotnikov AV, Baikova VN, Saltanov AI. Vozmozhnosti ispol'zovaniya novogo biomarkera sepsisa — presepsina. Vestnik intensivnoi terapii. 2015;2:23–28.
8. Yoshihiko Nakamura, Hiroyasu Ishikura, Takeshi Nishida, Yasumasa Kawano, Rie Yuge, Reiko Ichiki, Akira Murai. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiology. 2014;14:88.
9. Demidova V.S., Ushakova T.A., Zvyagin A.A., Bobrovnikov A.E., Medova O.V., Koryakov I.A., Baranova A.A., Samadurova L.L., Kucheinik A.Sh. Presepsin — ot nauki k praktike: klinicheskaya znachimost' markerov sepsisa pri infektsionnykh oslozhneniyakh u khirurgicheskikh bol'nykh i patsientov s ozhogovoi travmoi (FGBU «Institut khirurgii im. A.V. Vishnevskogo», Moskva). Tezisy XIX Vserossiiskoi nauchno-prakticheskoi konferentsii «Konsolidatsiya nauki i praktiki v laboratornoi meditsine», Moskva, MVTs «Krokus Ekspo», 25–27 marta 2014.
10. Kozlova E.M., Shun'kina G.L., Chumak N.M, Zapevalova T.A. Uroven' presepsina krovi u novorozhdennykh detei (GBUZ NO «Detskaya gorodskaya klinicheskaya bol'nitsa № 1», Nizhnii Novgorod). Tezisy XIX Vserossiiskoi nauchno-prakticheskoi konferentsii «Konsolidatsiya nauki i praktiki v laboratornoi meditsine», Moskva, MVTs «Krokus Ekspo», 25–27 marta 2014.
11. Makarova P., Galstyan G, Krechetova A, Gemdjian.E, Garandja T, Tichomirov D, Parovichnikova E. Usefulness of presepsin (PSP) for assessment of sepsis in leukopenis patients (pts). National Scientific Center for Hematology. Moscow, Russia, 18 sentyabrya 2014.
